Yi Chen
Stock Analyst at HC Wainwright & Co.
(3.75)
# 758
Out of 5,044 analysts
521
Total ratings
43.55%
Success rate
10.25%
Average return
Main Sectors:
Stocks Rated by Yi Chen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DRTS Alpha Tau Medical | Reiterates: Buy | $9 | $4.19 | +114.80% | 20 | Oct 22, 2025 | |
| OCUL Ocular Therapeutix | Maintains: Buy | $15 → $19 | $11.53 | +64.79% | 28 | Oct 8, 2025 | |
| OCS Oculis Holding AG | Maintains: Buy | $33 → $36 | $21.00 | +71.43% | 16 | Oct 7, 2025 | |
| ICCM IceCure Medical | Maintains: Buy | $2 → $2.5 | $0.76 | +226.88% | 23 | Oct 7, 2025 | |
| RGNX REGENXBIO | Reiterates: Buy | $34 | $13.16 | +158.36% | 13 | Oct 7, 2025 | |
| VNRX VolitionRx | Reiterates: Buy | $2.5 | $0.42 | +488.65% | 3 | Sep 30, 2025 | |
| AXGN Axogen | Initiates: Buy | $25 | $18.08 | +38.27% | 1 | Sep 30, 2025 | |
| HROW Harrow | Reiterates: Buy | $64 | $38.15 | +67.76% | 6 | Sep 29, 2025 | |
| KALA KALA BIO | Downgrades: Neutral | n/a | $0.83 | - | 24 | Sep 29, 2025 | |
| OKYO OKYO Pharma | Reiterates: Buy | $7 | $2.55 | +174.51% | 14 | Sep 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $98 | $93.24 | +5.11% | 21 | Sep 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $90 → $98 | $86.59 | +13.18% | 2 | Sep 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $4.24 | +65.09% | 20 | Sep 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $50 → $48 | $47.98 | +0.04% | 8 | Sep 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $10 | $3.79 | +163.85% | 5 | Sep 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $2.46 | +307.33% | 17 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $1.67 | +139.52% | 7 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $3.98 | +126.13% | 2 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $2.75 | +190.91% | 4 | Aug 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $11 | $1.87 | +488.24% | 2 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $53 → $54 | $30.37 | +77.81% | 5 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $8 | $3.27 | +144.65% | 20 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $32 | $28.01 | +14.24% | 3 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $13 | $6.15 | +111.38% | 10 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $23 | $12.25 | +87.76% | 23 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.32 | - | 24 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $16 | $15.20 | +5.26% | 19 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $4 | $0.95 | +319.95% | 7 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $75 | $3.90 | +1,823.08% | 22 | Jul 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $12.29 | +30.19% | 11 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $5 | $2.16 | +131.48% | 1 | Jun 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $10.62 | +69.49% | 1 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $25 | $14.67 | +70.42% | 12 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $38 → $39 | $9.43 | +313.57% | 8 | Apr 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3 | $1.44 | +108.33% | 14 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3 | $0.59 | +408.73% | 1 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.5 → $1 | $0.57 | +75.44% | 23 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3 | $1.30 | +130.77% | 13 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $3.65 | +721.92% | 20 | Jan 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.57 | - | 10 | Nov 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $500 | $6.99 | +7,053.08% | 5 | May 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $0.39 | +2,753.44% | 14 | Feb 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.49 | - | 7 | Jun 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $58 → $48 | $13.07 | +267.25% | 8 | Apr 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $19 | $74.44 | -74.48% | 2 | Feb 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.30 | - | 2 | Apr 16, 2020 |
Alpha Tau Medical
Oct 22, 2025
Reiterates: Buy
Price Target: $9
Current: $4.19
Upside: +114.80%
Ocular Therapeutix
Oct 8, 2025
Maintains: Buy
Price Target: $15 → $19
Current: $11.53
Upside: +64.79%
Oculis Holding AG
Oct 7, 2025
Maintains: Buy
Price Target: $33 → $36
Current: $21.00
Upside: +71.43%
IceCure Medical
Oct 7, 2025
Maintains: Buy
Price Target: $2 → $2.5
Current: $0.76
Upside: +226.88%
REGENXBIO
Oct 7, 2025
Reiterates: Buy
Price Target: $34
Current: $13.16
Upside: +158.36%
VolitionRx
Sep 30, 2025
Reiterates: Buy
Price Target: $2.5
Current: $0.42
Upside: +488.65%
Axogen
Sep 30, 2025
Initiates: Buy
Price Target: $25
Current: $18.08
Upside: +38.27%
Harrow
Sep 29, 2025
Reiterates: Buy
Price Target: $64
Current: $38.15
Upside: +67.76%
KALA BIO
Sep 29, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.83
Upside: -
OKYO Pharma
Sep 23, 2025
Reiterates: Buy
Price Target: $7
Current: $2.55
Upside: +174.51%
Sep 15, 2025
Maintains: Buy
Price Target: $100 → $98
Current: $93.24
Upside: +5.11%
Sep 12, 2025
Maintains: Buy
Price Target: $90 → $98
Current: $86.59
Upside: +13.18%
Sep 11, 2025
Reiterates: Buy
Price Target: $7
Current: $4.24
Upside: +65.09%
Sep 10, 2025
Downgrades: Neutral
Price Target: $50 → $48
Current: $47.98
Upside: +0.04%
Sep 4, 2025
Maintains: Buy
Price Target: $12 → $10
Current: $3.79
Upside: +163.85%
Sep 2, 2025
Reiterates: Buy
Price Target: $10
Current: $2.46
Upside: +307.33%
Sep 2, 2025
Reiterates: Buy
Price Target: $4
Current: $1.67
Upside: +139.52%
Sep 2, 2025
Reiterates: Buy
Price Target: $9
Current: $3.98
Upside: +126.13%
Aug 20, 2025
Reiterates: Buy
Price Target: $8
Current: $2.75
Upside: +190.91%
Aug 18, 2025
Maintains: Buy
Price Target: $10 → $11
Current: $1.87
Upside: +488.24%
Aug 18, 2025
Maintains: Buy
Price Target: $53 → $54
Current: $30.37
Upside: +77.81%
Aug 12, 2025
Maintains: Buy
Price Target: $12 → $8
Current: $3.27
Upside: +144.65%
Aug 8, 2025
Maintains: Buy
Price Target: $30 → $32
Current: $28.01
Upside: +14.24%
Aug 7, 2025
Maintains: Buy
Price Target: $14 → $13
Current: $6.15
Upside: +111.38%
Aug 6, 2025
Maintains: Buy
Price Target: $22 → $23
Current: $12.25
Upside: +87.76%
Aug 1, 2025
Downgrades: Neutral
Price Target: n/a
Current: $1.32
Upside: -
Jul 31, 2025
Maintains: Buy
Price Target: $15 → $16
Current: $15.20
Upside: +5.26%
Jul 29, 2025
Maintains: Buy
Price Target: $5 → $4
Current: $0.95
Upside: +319.95%
Jul 18, 2025
Downgrades: Neutral
Price Target: $75
Current: $3.90
Upside: +1,823.08%
Jul 16, 2025
Reiterates: Buy
Price Target: $16
Current: $12.29
Upside: +30.19%
Jun 27, 2025
Assumes: Buy
Price Target: $5
Current: $2.16
Upside: +131.48%
May 28, 2025
Initiates: Buy
Price Target: $18
Current: $10.62
Upside: +69.49%
May 5, 2025
Reiterates: Neutral
Price Target: $25
Current: $14.67
Upside: +70.42%
Apr 21, 2025
Maintains: Buy
Price Target: $38 → $39
Current: $9.43
Upside: +313.57%
Apr 7, 2025
Reiterates: Buy
Price Target: $3
Current: $1.44
Upside: +108.33%
Mar 31, 2025
Initiates: Buy
Price Target: $3
Current: $0.59
Upside: +408.73%
Mar 28, 2025
Maintains: Neutral
Price Target: $1.5 → $1
Current: $0.57
Upside: +75.44%
Mar 21, 2025
Reiterates: Buy
Price Target: $3
Current: $1.30
Upside: +130.77%
Jan 2, 2025
Reiterates: Buy
Price Target: $30
Current: $3.65
Upside: +721.92%
Nov 25, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.57
Upside: -
May 17, 2024
Reiterates: Buy
Price Target: $500
Current: $6.99
Upside: +7,053.08%
Feb 21, 2024
Reiterates: Buy
Price Target: $11
Current: $0.39
Upside: +2,753.44%
Jun 7, 2023
Downgrades: Neutral
Price Target: n/a
Current: $1.49
Upside: -
Apr 22, 2022
Maintains: Neutral
Price Target: $58 → $48
Current: $13.07
Upside: +267.25%
Feb 17, 2021
Maintains: Buy
Price Target: $18 → $19
Current: $74.44
Upside: -74.48%
Apr 16, 2020
Downgrades: Neutral
Price Target: n/a
Current: $1.30
Upside: -